tbuckley/cabot-search huggingface dataset:
Self Psychology and Psychosis: The Development of the Self During Intensive Psychotherapy of Schizophrenia and Other Psychosesby David Garfield and Ira Steinman. London, Karnac, 2015, 208 pp., $35.76 (paperback).
Authors: Andrés Barrera
Journal: American Journal of Psychiatry (2016)

deeper understanding of the patient's relationship with the therapist" is mentioned on page 1 as a valuable vehicle of insight and healing.What are presented are simplified conclusions and outcomes, such as, "Anna came to think of herself more coherently and with fewer dissociations" (p.40)."Malcolm reconsidered the present and new future, and how to move forward in a new way with his mentor" (p.45)."As a result of learning more adaptive assertiveness and responsibility, he was later promoted to a supervisory position" (p.60).Patient improvement is, of course, our goal.We have all experienced the satisfactions that come with helping patients, which both gratify our desires to help and seemingly assure us of the correctness of our theories and techniques.What leads me to feel somewhat separated from the author's clinical reports is that he apparently privileges the therapist's psychoeducational interventions and soothing "serenity" as the vehicles of healing more than my clinical experiences have led me to believe.The "new relationship" is certainly vital.We help our patients experience this new relatedness in our surprising (to them) open-minded welcoming into the office of their feared desires, imaginings, and awkward self-representations.That is, we strive to help patients discover both that they have childhood-derived fears, hopes, shames, and excitements and that we receive them, are interested in them, and encourage their awareness and acceptance of them.This is our offer of therapeutic love, and patients' acceptance of that offer is a key component of adult personality growth that deserves mention in a book with that title.Dr. Horowitz's artwork on the book jacket is, significantly, not of his elegant and serene sumi-e but rather is an oil painting of a forest scene with gnarled trees, impressionistic greenery, and dense plant growth.This is the stuff of therapy.This is the wonderful messiness that patients bring to us that we are privileged to encounter.Many of us have learned from Dr. Horowitz for decades, going back to his groundbreaking work on stress.He now brings us his efforts to importantly integrate cognitive and dynamicthinking.I look forwardto our continuingto learn fromhim.
TCT-762 Renal denervation treatment with the Symplicity Spyral multielectrode catheter: 6-month safety and blood pressure outcomes from the Global SYMPLICITY Registry
Authors: Michael Böhm, Nicole Brilakis, Giuseppe Mancia, Krzysztof Narkiewicz, Luis Ruilope, Markus Schlaich, Felix Mahfoud
Journal: Journal of the American College of Cardiology (2016)
TCT-605 Introduction of a Novel and Robust Parameter to Quantifiy Coronary Plaque Burden by OCT: Evaluation of Feasibility, Interobserver Analysis and Graphical Illustration of “Luminal Surface Plaque Area”
Authors: Sylvia Otto, Kristina Nitsche, Bjoern Goebel, P. Christian Schulze, Hans R. Figulla, Tudor Poerner
Journal: Journal of the American College of Cardiology (2016)
Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering
Authors: Paola Campagnolo, Adam J. Gormley, Lesley W. Chow, Anne Géraldine Guex, Paresh A. Parmar, Jennifer L. Puetzer, Joseph A. M. Steele, Alexandre Breant, Paolo Madeddu, Molly M. Stevens
Journal: Advanced Healthcare Materials (2016)

The development of synthetic vascular grafts for coronary artery bypass is challenged by insufficient endothelialization, which increases the risk of thrombosis, and the lack of native cellular constituents, which favors pathological remodeling. Here, a bifunctional electrospun poly(ε‐caprolactone) (PCL) scaffold with potential for synthetic vascular graft applications is presented. This scaffold incorporates two tethered peptides: the osteopontin‐derived peptide (Adh) on the “luminal” side and a heparin‐binding peptide (Hep) on the “abluminal” side. Additionally, the “abluminal” side of the scaffold is seeded with saphenous vein‐derived pericytes (SVPs) as a source of proangiogenic growth factors. The Adh peptide significantly increases endothelial cell adhesion, while the Hep peptide promotes accumulation of vascular endothelial growth factor secreted by SVPs. SVPs increase endothelial migration both in a transwell assay and a modified scratch assay performed on the PCL scaffold. Seeding of SVPs on the “abluminal”/Hep side of the scaffold further increases endothelial cell density, indicating a combinatory effect of the peptides and pericytes. Finally, SVP‐seeded scaffolds are preserved by freezing in a xeno‐free medium, maintaining good cell viability and function. In conclusion, this engineered scaffold combines patient‐derived pericytes and spatially organized functionalities, which synergistically increase endothelial cell density and growth factor retention.
TCT-386 Incidence and prevention of contrast induced acute kidney injury in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
Authors: Grigoris Karamasis, Firas Al-Janabi, Shah Mohdnazri, Rohan Jagathesan, Alamgir Kabir, Jeremy Sayer, Nicholas Robinson, Gerald Clesham, Rajesh Aggarwal, Reto Gamma, Paul Kelly, Kare Tang, John Davies, Thomas Keeble
Journal: Journal of the American College of Cardiology (2016)
Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupus-associated polymorphism FcγRIIB-T232
Authors: Liling Xu, Mengdie Xia, Jun Guo, Xiaolin Sun, Hua Li, Chenguang Xu, Xiaomei Gu, Haowen Zhang, Junyang Yi, Yan Fang, Hengyi Xie, Jing Wang, Zhixun Shen, Boxin Xue, Yujie Sun, Tobias Meckel, Ying-Hua Chen, Zhibin Hu, Zhanguo Li, Chenqi Xu, Haipeng Gong, Wanli Liu
Journal: The Journal of Experimental Medicine (2016)

FcγRIIB functions to suppress the activation of immune cells. A single-nucleotide polymorphism in the transmembrane (TM) domain of FcγRIIB, FcγRIIB-T232, is associated with lupus. In this study, we investigated the pathogenic mechanism of FcγRIIB-T232 at both functional and structural levels. Our results showed that FcγRIIB-T232 exhibited significantly reduced lateral mobility compared with FcγRIIB-I232 and was significantly less enriched into the microclusters of immune complexes (ICs) after stimulation. However, if sufficient responding time is given for FcγRIIB-T232 to diffuse and interact with the ICs, FcγRIIB-T232 can restore its inhibitory function. Moreover, substituting the FcγRIIB-T232 TM domain with that of a fast floating CD86 molecule restored both the rapid mobility and the inhibitory function, which further corroborated the importance of fast mobility for FcγRIIB to function. Mechanistically, the crippled lateral mobility of FcγRIIB-T232 can be explained by the structural changes of the TM domain. Both atomistic simulations and nuclear magnetic resonance measurement indicated that the TM helix of FcγRIIB-T232 exhibited a more inclined orientation than that of FcγRIIB-I232, thus resulting in a longer region embedded in the membrane. Therefore, we conclude that the single-residue polymorphism T232 enforces the inclination of the TM domain and thereby reduces the lateral mobility and inhibitory functions of FcγRIIB.
First-line trastuzumab utilization: Patterns of care and progression in the community setting
Authors: S. K. Gruschkus, J. A. Shankleton, M. Brammer, M. Forsyth, D. Lalla
Journal: Journal of Clinical Oncology (2009)

e12009 Background: This study describes patterns of care and outcomes in metastatic breast cancer (MBC) patients treated with trastuzumab (T) within the US Oncology network. Methods: This retrospective study utilized data from US Oncology's iKnowMed EMR system. HER-2 (+) MBC patients who initiated a first-line regimen containing T between January 1, 2006 and July 31, 2007, were identified. Patients were divided into three treatment cohorts: A) those who discontinued T prior to disease progression; B) those who continued T following discontinuation of chemotherapy prior to progression; and C) those who received T monotherapy. Patients were followed through October 31, 2008, to measure treatment duration and observe progression (as defined as escalation to second-line therapy). The Kaplan Meier method/log-rank test were used to estimate and compare progression free survival (PFS) across cohorts. Results: We identified 139 patients receiving first-line therapy including T. The median age was 58 years and 84 patients were ER and/or PR (+). The top 5 chemotherapy regimens included T plus: paclitaxel (n = 14); docetaxel (n = 14); vinorelbine (n = 14); carboplatin/paclitaxel (n = 12); carboplatin/docetaxel (n = 7 pts). Twenty-one (15%) patients were in cohort A, 55 (40%) were in cohort B, and 63 (45%) were in cohort C. Overall, the median duration of first-line T use was 281 days (mean = 287; range = 1–862). Following the initiation of first-line therapy, a total of 56 (40%) patients progressed (median follow up = 15 months). Following progression, 22 (39%) patients received second-line regimens containing T. The overall median PFS was 17.4 months (mean = 18.6). Patients in cohort A (n = 15) had significantly shorter PFS versus patients in cohort B/C (median 3.9 and 19.6 months, respectively; p &lt; 0.001). Conclusions: In this observational study within the outpatient community setting, persistent first-line T use for MBC was associated with delayed disease progression. Future research should evaluate the causal relationship of this association. In addition, a more comprehensive evaluation should be conducted of therapies prescribed concomitant to T for patients treated with T “monotherapy.” [Table: see text]
TCT-290 Establishing a dedicated program for treating chronic coronary total occlusions. Clinical results before and after routinely using retrograde revascularization techniques
Authors: Martin Kirk Christensen, Philip Freeman, Bent Raungaard, Anton Boel Villadsen, Jens Aaroe, Svend Eggert Jensen, Jeppe Rasmussen, Jan Ravkilde, Leif Thuesen
Journal: Journal of the American College of Cardiology (2016)
TCT-132 Utility of the SAVE Score as a Predictor of Survival in Cardiogenic Shock Requiring VA-ECMO or Impella for Acute Mechanical Circulatory Support
Authors: Sudeep Kuchibhotla, Michele Esposito, David Zisa, Ryan O'Kelly, Shiva Annamalai, Adel Ghuloom, Leslie Lussier, Catalina Breton, Tobias Rheude, Andrew Mullin, Carey Kimmelstiel, Michael Kiernan, Amanda Vest, Navin Kapur
Journal: Journal of the American College of Cardiology (2016)
TCT-841 Combined Coronary Artery Imaging for Plaque Characterization in Preclinical Studies: An OCT-IVUS-Histological Study of the Familial Hypercholesterolemic Swine Model
Authors: Armando Tellez, Pawel Gasior, Dhanansayan Shanmuganayagam, Gerard Conditt, Yanping Cheng, Nicolette D. Jackson, Krista N. Dillon, Dane A. Brady, CHRISTIAN KRUEGER, Serge Rousselle, Greg Kaluza, Juan Granada
Journal: Journal of the American College of Cardiology (2016)
TCT-618 Safety and Efficacy of Left Atrial Appendage Closure With the Watchman Device in Patients Older Than 85 Years Old: Data From the Prospective EWOLUTION Registry
Authors: Ignacio Cruz Gonzalez, Hüseyin Ince, Boris Schmidt, Pascal Defaye, Leif-Hendrik Boldt, Robin Molitoris, Jean-Benoit Thambo, Christof Wald, Kenneth Stein, Lucas Boersma
Journal: Journal of the American College of Cardiology (2016)
TCT-44 Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty In A Large, Consecutive Cohort Followed For More Than Two Decades
Authors: Alfredo Nunes Ferreira Neto, Jose Costa, Nisia Lira Gomes, Auristela Ramos, Mercedes Maldonado, Rafael Alexandre Meneguz-Moreno, Dimytri Siqueira, Zilda Meneghelo, Cesar Augusto Esteves, Sergio Braga, Amanda Sousa, Alexandre Abizaid
Journal: Journal of the American College of Cardiology (2016)
TCT-21 Door-to-ECMO before Door-to-Balloon? Early Implementation of ECMO might improve the Survival of Patients with STEMI Complicated by Refractory Cardiogenic Shock
Authors: Chi-Cheng Huang, Pen-Chih Liao, Shin-Rong Ke, Jung-Cheng Hsu
Journal: Journal of the American College of Cardiology (2016)
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
Authors: Juan E. Grunwald, Maxwell Pistilli, Ebenezer Daniel, Gui-Shuang Ying, Wei Pan, Glenn J. Jaffe, Cynthia A. Toth, Stephanie A. Hagstrom, Maureen G. Maguire, Daniel F. Martin
Journal: Ophthalmology (2016)
OP043D CULTURE OF MURINE NEURAL STEM CELLS ON DECELLULARIZED MOUSE BRAIN SECTIONS
Authors: Jorrit De Waele, Kristien Reekmans, Jasmijn Daans, Zwi Berneman, Peter Ponsaerts
Journal: Neuro-Oncology (2015)

INTRODUCTION: Their inherent tumour tropism renders neural stem cells (NSC) intriguing as tumour-targeting gene therapy vehicles for brain cancers. However, effective cell therapy relies on the intrinsic capacity of cellular grafts to overcome hypoxic and/or immunological barriers during transplantation. In this context, it is hypothesized that structural support for grafted NSC - in the form of a 3D biocompatible matrix - will be of utmost importance. METHOD: A protocol to decellularize 1.5 mm thick mouse brain sections was designed and validated using molecular analysis and microscopy. Next, the resulting extracellular matrix (ECM) scaffolds were seeded with murine NSC expressing both eGFP and luciferase. Bioluminescence imaging was used to monitor survival and growth. Phenotype was evaluated using confocal microscopy and compared to standard 2D cultured NSC. RESULTS: We optimised and validated a novel decellularization protocol for 1.5 mm thick mouse brain sections, resulting in the generation of acellular 3D brain tissue-derived ECM scaffolds. These 3D ECM scaffolds supported long-term ex vivo survival and growth of NSC during a 2-13 week monitoring period. Confocal microscopy revealed the 3D organisation of scaffold-supported NSC cultures. Under mitogenic stimuli, most cells in this 3D culture retained the NSC phenotype, with only a small minority undergoing spontaneous differentiation. CONCLUSION: The development of this new 3D NSC culture system will become useful for new research on the development of neural networks, brain tumour remodelling, drug testing and brain cell transplantation research. Moreover, it may offer a new modality for 3D in vitro brain research when using brain cancer stem cells.
TCT-342 Incomplete Revascularisation and 12-month Mortality in Octogenarians Undergoing Percutaneous Coronary Intervention: Support for a Conservative DES-Driven Strategy
Authors: Fairoz Belary Abdul, Nick Ossei-Gerning, Anirban Choudhury, James Cockburn, Richard Anthony Anderson, Mamas Mamas, None tim kinnaird
Journal: Journal of the American College of Cardiology (2016)
ERCC1 expression and survival in small cell lung cancer
Authors: M. Hennemann, M. H. Sostruznik, A. M. Gaiger, C. H. Barrios
Journal: Journal of Clinical Oncology (2009)

e19080 Background: The excision repair cross-complementation group 1 (ERCC1) protein expression has been suggested as both predictive or prognostic according to the administration or not of cisplatin-based chemotherapy in non-small cell lung cancer. It's role in small cell lung cancer (SCLC) is still uncertain. Methods: Forty four patients (pts) with diagnosis of SCLC were retrospectively analyzed. Paraffin blocks were reviewed to reconfirm a SCLC diagnosis and submitted to semi-quantitative immunohistochemical (ICH) method to detect the ERCC1 protein. The criteria for ERCC1 IHC evaluation was based on the percentage of cells with positive staining. Medical charts were reviewed and findings correlated to the IHC expression. All pts were treated with standard cisplatin-based chemotherapy and concomitant radiotherapy when appropriate according to stage. We report the correlation of ERCC1 expression with the overall survival of the population. Results: The group of pts had 59% (n=26) men with a median age of 60,8 years (±10). Staging revealed limited disease (LD) in 41% (n=18), extensive disease (ED) in 55% (n=24) and was not available from the chart review in 7% (n=3). The median survival time (MST) was 15.84 (±9.73) months (mo) in LD; 8.39 (±8.53) mo in ED. ERCC1 was positive in 50% (n=22) of the pts. From these, 54% (n=12) had ≥50% of the cells with positive staining. The overall median survival of this group was 10.8 (±8.6) mo. The 45% (n=10) of cases presenting with &lt;50% of cells with positive staining had an overall survival of 13 (±10) mo. In the group with positive ERCC1 expression, 45%(n=10) had LD and median survival of 17.1 (±7.8) mo [≥50% staining (n=6): median survival 12.1 (±3.9) mo; &lt;50% staining (n=4): median survival 24.4 (±6.1) mo]. The 11 pts with ERCC1 expression and ED had a median survival of 7.9 (±8.7) mo. [≥50% staining (n=6): median survival 9.4 (±12) mo; &lt;50% staining (n=5): median survival 6.1 (±1.5) mo]. The group with no ERCC1 expression (n=22)] had an overall survival of 9.7 (±10.1) mo. Of these pts 7 had LD and a median survival of 14.03 (±12.4) mo, while 13 pts had ED and a median survival of 8.76 (±8.73) mo. Conclusions: In this group of SCLC pts ERCC1 expression by IHC does not seem to correlate with survival. No significant financial relationships to disclose.
Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells By Combining Therapeutic Antibodies with CD20-Specific Immunoligands Engaging NKG2D or NKp30
Authors: Matthias Peipp, Christian Kellner, Andreas Günther, Andreas Humpe, Roland Repp, Katja Klausz, Stefanie Derer, Thomas Valerius, Jan G.J. van de Winkel, Paul W.H.I. Parren, Martin Gramatzki
Journal: Blood (2014)
Quantitative Monitoring By RT-PCR of Molecular Markers on Day +100 after Allogeneic Stem Cell Transplantation Predicts Outcome in Patients with Acute Myeloid Leukemia
Authors: Max Hubmann, Christina Zeber, Markus Pfirrmann, Thomas Koehnke, Nicole Engel, Susanne Fritsch, Dusan Prevalsek, Stephanie Schneider, Annika Dufour, Evelyn Zellmeier, Roland Reibke, Hans-Jochem Kolb, Marion Subklewe, Michael Fiegl, Wolfgang Hiddemann, Karsten Spiekermann, Johanna Tischer
Journal: Blood (2014)
TCT-169 The impact of a door-to-balloon time of less than 30 minutes on the in-hospital mortality in patients with ST elevation myocardial infarction
Authors: Takeshi Yamada, Yukio Mizuguchi, Akihiko Takahashi, Hiroki Shibutani, Sho Hashimoto, Norimasa Taniguchi, Shunsuke Nakajima, Tetsuya Hata
Journal: Journal of the American College of Cardiology (2016)
High p53 Protein Expression LEVEL Independent Of Mutational Status Is An Adverse Prognostic Factor For Survival In ACUTE Myeloid Leukemia
Authors: Alfonso Quintas-Cardama, Sean M. Post, Kensuke Kojima, Yi Hua Qiu, Michael Andreeff, Carlos E. Bueso-Ramos, Steven M. Kornblau
Journal: Blood (2013)
Management of skin cancer in the frail elderly: time for a rethink?
Authors: J.K. Schofield, E. Linos, J. Callander
Journal: British Journal of Dermatology (2016)

Imagine, the end of a busy dermatology clinic. The nurse comes in to rearrange the chairs, as the last patient is in a wheelchair. He is accompanied by two elderly individuals, who introduce themselves as the patient's daughter and son. They explain that their 98‐year‐old father is deaf, and has memory impairment, but still lives alone, with support from family and carers; they continue to speak on his behalf, this being the norm. They explain that their father has developed a non‐painful, scabbed lesion on the left ear over the last 6 months. When the scab has been carefully removed, and the area cleaned, it is apparent that he has an ulcerated area on the left posterior auricular area with rolled borders and telangectasia, measuring 3 cm along its’ long axis. The history and clinical features suggest the diagnosis of basal cell carcinoma; what should we do for this particular patient? What do the guidelines say?
Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation
Authors: Luigi Di Biase, J. David Burkhardt, Prasant Mohanty, Sanghamitra Mohanty, Javier E. Sanchez, Chintan Trivedi, Mahmut Güneş, Yalçın Gökoğlan, Carola Gianni, Rodney P. Horton, Sakis Themistoclakis, G. Joseph Gallinghouse, Shane Bailey, Jason D. Zagrodzky, Richard H. Hongo, Salwa Beheiry, Pasquale Santangeli, Michela Casella, Antonio Dello Russo, Amin Al-Ahmad, Patrick Hranitzky, Dhanunjaya Lakkireddy, Claudio Tondo, Andrea Natale
Journal: Journal of the American College of Cardiology (2016)
TCT-203 Dual versus triple anti thrombotic therapy in Acute Coronary Syndromes - A meta analysis
Authors: Mahesh Anantha Narayanan, Nagarjuna Gujjula, Dixitha Anugula, Yogesh NV. Reddy, Janani Baskaran, Ganesh Raveendran
Journal: Journal of the American College of Cardiology (2016)
TCT-315 Stent fracture and peri-stent contrast staining after everolimus-eluting stent implantation: 5-year clinical outcome
Authors: katsuya miura, Kazushige Kadota, Akimune Kuwayama, Masanobu Ohya, Takenobu Shimada, Hidewo Amano, Shunsuke Kubo, Yusuke Hyodo, Suguru Otsuru, Seiji Habara, Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Tsuyoshi Goto
Journal: Journal of the American College of Cardiology (2016)
TCT-175 Myocardial Wash Grade in Evaluation of Reperfusion Therapy in Acute Myocardial Infarction
Authors: Tasuku Higashihara, Keigo Dote, Masaya Kato, Shota Sasaki, Noboru Oda, Eisuke Kagawa, Michiaki Nagai
Journal: Journal of the American College of Cardiology (2016)
UTILIDAD DE UNA PRÓTESIS PANCREÁTICA CON MARCADOR RADIOLÓGICO COMO AYUDA PARA CANULAR EL COLÉDOCO CUANDO EL PACIENTE ESTÁ EN DECÚBITO LATERAL IZQUIERDO EN LA CPRE
Authors: J García-Cano, E Bermejo Saiz, C Murillo Matamoros, Y Jiménez Martínez, M Muñiz Muñoz, T Martínez Pérez, L Valiente González, R Martínez Fernández, M Viruelas Chicano
Journal: Endoscopy (2016)

Introducción: La situación ideal del paciente para realizar una CPRE es en decúbito supino o prono. De esta forma los ejes del colédoco y del páncreas están separados y en los intentos de canulación de la vía biliar con guía es fácil reconocer en la fluoroscopia qué conducto se ha canulado (figura 1). Sin embargo, en ocasiones los pacientes están situados en decúbito lateral izquierdo debido a problemas respiratorios, preferencia de los anestesiólogos o mayor comodidad para los enfermos. En estas circunstancias puede confundirse el conducto que se ha canulado con la guía.
TCT-291 Predictors of Successful Hybrid-Approach CTO Stenting: An Improved Model with Refined Correlates
Authors: Stephen Ellis, Ramy Badawi, M. Nicholas Burke, Bilal Murad, John Graham, Catalin Toma, Henry Meltser, Ravi Nair, Christopher Buller, Patrick Whitlow
Journal: Journal of the American College of Cardiology (2016)
TCT-476 A Randomized Comparison of Novel Biodegradable Polymer- and Durable Polymer-Coated Cobalt-Chromium Sirolimus-Eluting Stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial
Authors: Bo Xu, Changdong Guan, Quanmin Jing, Kai Xu, Yuejin Yang, Yaling Han
Journal: Journal of the American College of Cardiology (2016)
Effect of danhong injection on the mobilisation of endothelial progenitor cells to vascular repair after percutaneous coronary intervention: a randomised controlled trial
Authors: Zhen Hu, Hong Wang, Guanwei Fan, Han Zhang, Xiaoying Wang, Jingyuan Mao, Yingqiang Zhao, Yi An, Yuhong Huang, Chuan Li, Lianying Chang, Xianming Chu, Li Li, Yanfen Li, Yuan Zhang, Gangjian Qin, Xiumei Gao, Boli Zhang
Journal: The Lancet (2016)
TCT-158 Treating Periodontal Disease in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial
Authors: Marcelo Gomes Lobo, Thiago Dipp, Ivan Petry, Karine Schmidt, Marcia Moura, Cristina Gazeta, Mariana Azeredo, Yan Wang, Renato Lopes, Lucia Pellanda, Carlos Gottschall, Keyvan Karimi Galougahi
Journal: Journal of the American College of Cardiology (2016)